Home / Data / Corporate Press Release Ledger / 0001140361-26-034854 0001140361-26-034854 The Corporate Press Release Ledger tracks 8-K Regulation FD and Item 7.01 and 8.01 press-release filings with extracted exhibit titles, detected wire services and topic families, drawn from public SEC EDGAR data over a rolling window and refreshed daily. Every entry links the official filing; topics are derived labels, not issuer claims.
Records 4,303
Last changed 09/03/2026
Update schedule 11 13 * * * UTC
Coverage 07/20/2026–09/03/2026
Filing Date 08/28/2026
Issuer Roivant Sciences Ltd.
Press Release Title LISRAYA (brepocitinib) Approved for Treatment of Patients with Dermatomyositis August 28, 2026 For investor audiences only
Release Topic earnings
Wire Service Detected —
Is Reg Fd false Source U.S. Securities and Exchange Commission, EDGAR submissions, indexes, and filings · official record · retrieved 09/04/2026 · upstream last modified 08/28/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Securities and Exchange Commission
Required notice Automated requests declare VUGA Enterprises LLC and an operator contact in the User-Agent header. What we add We compute Is Reg Fd, Has Press Release Exhibit, Release Topic, Release Topics All, Wire Service Detected, Release Length Words, Same Day Release Count, Issuer Sector, Public Significance Score using the documented compute method. · methodology